Label-free imaging of a developing thrombus 23
Platelets are specialized anucleate blood cells that are essential for maintaining hemostasis. Hemostasis, 2 the process of maintaining a normal blood volume, which often involves the forming of a blood clot 3 (thrombus). Thrombus formation is initiated by adhesion of circulating blood platelets onto exposed 4 extracellular matrix proteins, including collagen and von Willebrand Factor (VWF), within a damaged 5 vascular wall. Adhered platelets then release secondary agonists/mediators and promote thrombin 6 generation, which helps recruit additional platelets to the injured site, cumulatively building a thrombus. 7
Under pathophysiological conditions, this normally protective cascade of events can result in arterial 8 thrombosis or deep vein thrombosis, which can be responsible for major clinical events such as heart 9 attack and stroke. 10
Real time monitoring of thrombus formation under fluidic settings is vital for studying the 11 thrombotic process and provides significant insight to studying dynamic platelet function [1, 2] . Studying 12 the initial molecular events as a thrombus develops are crucial to understanding the involvement of key 13 platelet receptors and can also help in assessing platelet dysfunction in patients with genetic defects [2] . 14 Measuring the growth of a thrombus would be useful in identifying targets to reduce pathophysiological 15 events such as arterial thrombosis. Finally, the ability to study thrombus stability at pathological shear 16 rates will inform on molecular processes involved in embolization, and facilitate the development of 17 therapeutic avenues to treat venous thrombosis. 18
A developing thrombus can be classified into a series of morphological transitions along a high 19 fluid shear. The transition starts off with the initial activation of platelets through engagement of platelet 20 signalling receptors which trigger activation of platelet integrin receptors and drive the aggregation of 21 platelets that leads to thrombus growth before undergoing contraction [3, 4] . The contractile forces [5] from 22 the platelet are in part due to the interaction with the surrounding fibrin network [6] . On top of that, the 23 degree of activation of each platelet in the thrombus influences how the platelets engage each other; fully 24 4 activated platelets are held together within the thrombus by fibrinogen binding and bridging adjacent 1 integrin IIb3 receptors. Over time, adherent and fully activated platelets form the stable core of a 2 thrombus, and newly-arrived, less-activated platelets are more loosely packed and held together forming 3 a shell-like zone. The molecular composition of the thrombus core and shell affect the overall structural 4 stability of the thrombus [7] . To understand the basic biological processes underpinning thrombus growth 5 and regulation of that growth, it is important to visualize the morphological development of a thrombus 6 in real time using high speed imaging instruments that directly capture multiple views of a single 7 thrombus and quantitates parameters including volume, height and area, simultaneously and temporally. 8
Fluorescence intensity emitted from platelet-targeted fluorescent probes and surface markers are 9 used to map out the overall architecture of thrombus [8, 9] . The two main fluorescence imaging methods 10 are wide field fluorescence microscopy (WFM) and confocal laser scanning microscopy (CLSM) [10] . 11
In WFM, the changes of fluorescence intensity over a given area are used to estimate the volume of the 12 thrombus. The advantage of WFM imaging is the speed of acquisition, which is limited by the frame rate 13 of the imaging camera and also the brightness of the fluorescence signals. The fluorescence signal 14 collected on a digital imaging camera is integrated from a single imaging focal depth of around 8 µm 15
(based on objective of magnification 10x and NA 0.25) [11] [12] [13] . This means that the capacity to measure 16 the thickness of thrombus is restricted by the focal depth of the imaging lenses used. Therefore, if a 17 thrombus is larger than the focal depth, the quantification would encounter inaccuracies in volume 18 quantification [14, 15] . To circumvent this, most researchers have turned to more precise CLSM imaging 19 that captures the whole thrombus through multiple two dimensional thin imaging slices recorded by raster 20 scanning at a focused laser spot. This technique offers more accurate depth and thickness quantification 21 along with area and density of a thrombus [2, 16, 17] . The full 3D images acquired from CLSM imaging 22 requires repeated scanning of a laser beam across the sample through mechanical devices such as 23 galvanometer mirrors [2, 16, 17] of around 2 Hz at full frame or by spinning disc [18] that can reach 1000 Hz. 24
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The scanning process also exposes sample to higher light irradiation that can result in photobleaching [19] 1 or photodamage [20] . In fluorescence imaging, there is an additional complication introduced by binding 2 fluorescently-conjugated antibodies to the platelet surface to provide specificity. Recently, quantitative 3 phase microscopy (QPM) techniques have provided new opportunities to measure thrombus formation 4 in vitro [21] . QPM maps out the difference in refractive index instead of using endogenous fluorescence 5 signal and records thickness of the sample directly. However, since refractive index differences in 6 biological samples are non-specific, this quantification tool requires a careful choice of biological 7 samples [22, 23] . 8 QPM is usually in two forms, non-holographic and holographic type. The non-holographic QPM 9
[23] combines existing imaging optics of a WFM with numerical phase calculation and a prior knowledge 10 to estimate the phase (refractive index difference) before it can generate a reconstructed volume of the 11 sample. Although it has the same optical limitation as a conventional WFM, it provides volumetric 12 quantification that is not available in conventional WFM, albeit at the low imaging speed. Holographic 13 QPM [24] [25] [26] , on the other hand, directly records the phase of the object and uses a non-focussed laser light. 14 This method is not limited by the focal depth of the imaging optics in WFM or a focus laser beam in 15 CLSM. The recorded phase also removes undesired optical distortion arising from any artefact or 16 deformation within the sample [27, 28] which is important especially when dealing with samples of high 17 scattering signals such as blood samples. Recently, Boudejltia and colleagues [29] [30] [31] showed that QPM 18 can quantify individual platelet adhesion and other groups [32] have also began to using non-holographic 19 QPM techniques to quantify the mass of the final thrombus. All in all, the application of QPM techniques 20 in platelet and thrombus studies is in their infancy because of the lack of physiological relevant outcomes. 21
We argue that QPM is uniquely positioned to present comprehensive and direct multi-dimensional 22 morphological information of a developing thrombus, which would not be straightforward in other 23 imaging modalities. 24 Table 1 and Figure 1 present the three imaging modalities; WFM, CLSM and QPM that are 1 typically used to quantify thrombus. Table 1 lists out the performances of the three modalities. Figure  2 1a) illustrates the dynamic growth of a thrombus under flow at different time points (t1 to t3). Figure 1b ) 3 shows how WFM imaging captures the integrated fluorescence over a given thrombus. Figure 1c ) 4 illustrates the multiple thin image slices (Z0 to Zn) that depict recorded fluorescence intensities at each 5 slice, I(zi), from which CLSM retrieves the thrombus volume. The repeated scanning of a highly focused 6 laser beam causes an ineluctable lag time of round trip scanning which increases the overall acquisition 7
time. Figure 1d) shows how QPM imaging methods directly measure the refractive index difference of 8 the thrombus which is directly translated to integrated volume. Another advantage in QPM is that the 9 volume does not depend on the brightness emitted from the sample or the dynamic range of the detector 10 as compared to WFM. 11
By demonstrating that QPM can measure dynamic events and parameters such as volume, height 12 and area simultaneously and temporally at the different stages of thrombus formation and at multiple 13 viewing points, this will enable a high throughput morphological mapping of thrombus development and 14 greatly accelerate the understanding of early stages of thrombus development in a flow assay. A well 15 developed and robust imaging framework using holographic QPM techniques also lends itself to on-chip 16 holographic imaging techniques that be directly applied to diagnosing disorders of platelet function [33, 17 34] . 18
Results

19
We used platelet-rich plasma (PRP) in a microfluidic environment to obtain optical holograms of 20 thrombus formation (in this context, platelet-platelet aggregates formed through platelet deposition on to 21 collagen), which were digitally recorded on a high speed digital camera [35] . We used automated image 22 processing [36] for rapid quantification of individual thrombi over a given field of view. Within a single 23 acquisition, we directly generate multi-parameter datasets including thrombus volume, height and surface7 area. Since optical holograms record all volumetric information in a single snapshot, there is no 1 requirement to actively change the focus position of the imaging lenses. As the holograms are essentially 2 2D images, it enables directly volumetric imaging and the speed is limited only by the camera frame rate 3 (150 fps). Figure 2 shows the diagram of holographic QPM imaging and microfluidic setup. In Figure  4 2a) i) and ii) shows the actual microfluidic chips and the corresponding cross-sectional sketch 5 respectively. Figure 2a) iii) depicts the position of the imaging microscopy objective (MO) that is placed 6 under the microfluidic chip to collect the exiting laser light through the sample. The exiting laser light is 7 recombined with a reference laser light at a CCD camera using a beam splitter. The interference pattern 8 of the two laser light fields creates the optical hologram. A syringe pump was used in suction mode to 9 draw the sample; either whole blood (with heparin (10 U/mL) or 3.2% tri-sodium citrate used as an 10 anticoagulant) or platelet-rich plasma (PRP), collected from heparinized or citrated blood, across a 11 collagen-coated microfluidic chip surface, minimizing unnecessary sample shear stress prior to entry into 12 the microfluidic slide. The direction of flow is represented by the arrows (Figure 2a ). Due to difference 13 in flow margination between platelet rich plasma (PRP) and whole blood, different regions within the 14 flow channel are more prone to aggregation. For example, aggregates from PRP formed close to edges 15 of the channel whereas aggregates in whole blood tended to form in the middle of the channel. To ensure 16 fair comparison, we selected thrombi that were formed within defined regions 100 µm from the channel 17 side walls. Additional information of the sample and microfluidic chip preparations is discussed in the 18 experimental section. 19
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 From growth to reduction 21 During thrombus formation, the different levels of activation of the platelets contribute to the overall 22 packing density which affects physical stability of the adhering thrombus. During the initial stage of 23 thrombus formation, there is a steady increase in volume which is followed by an overall thrombus 24 8 consolidation/contraction [37] . During physiological thrombus formation where fibrin is generated, the 1 thrombus contraction is mediated in part by activated platelets pulling on fibrin networks to form a 2 closely packed core [38] . The morphological change in the thrombus is orchestrated by mechanical and 3 biochemical cues received by a formed thrombus. It has been showed that rate of diffusion of agonist 4 within the thrombus is regulated by how platelets are packed [39] . The anticoagulated blood used in this 5 work to generate thrombi refers to the quantification of platelet deposition and platelet-platelet 6 aggregation and that the process of fibrin generation was not studied. 7
To investigate the morphological changes in thrombus formation, we perfused PRP over collagen-coated 8 microfluidic channels at three different flow rates that produce fluid shear rates that are physiological 9 relevant to thrombus formation at 72 µL/min (1800 s -1 shear rate; 18 dyne/cm 2 shear stress), 144 µL/min 10 (3600 s -1 shear rate; 36 dyne/cm 2 shear stress) and 288 µL/min (7200 s -1 shear rate; 72 dyne/cm 2 shear 11 stress) for 10 min. To investigate the parameters of thrombi formed under flow of whole blood, we 12 perfused heparinized whole blood over collagen-coated microfluidic channels for 10 min at two different 13 flow rates, with equivalent shear stress to PRP samples, 32 µL/min (800 s -1 shear rate; 36 dyne/cm 2 shear 14 stress) and 72 µL/min (1600 s -1 shear rate; 72 dyne/cm 2 shear stress). The detailed conversion of shear 15 stress, shear rate and flow rate can be found in Experimental section. The field of view for capturing 16 dynamic thrombus formation was fixed on sections close to the inlet within ~ 800 ±200 µm after the 17 inlet, for all the measurements to ensure consistency and minimal exposure to turbulent flow. Volumetric 18 information was later reconstructed through classical holographic numerical approaches (see 19 Experimental section). linear growth followed by plateau, which is similar with previously reported growth trends [38] and mostly 3 similar shape to growth trends of citrated PRP (Supplementary Figure A2) . To quantify the growth rate, 4 two linear fits (R-square above 0.9) were applied to the growth and plateau segments respectively, 5 marked by black lines and S1 and S2. S1 represents the speed of the volume accumulation before the 6 maximum point. S2 represents the speed volume reduction after the maximum point. The statistics 7 average of growth rate S1 (the positive Y axis) and reduction rate S2 (the negative Y axis) from all donors 8 are presented in Figure 2 c ) ii). The influence of the shear rate appears to be more dominant at 7200 s -1 9 compared with shear rates of 1800 s -1 and 3600 s -1 . While higher shear rates seem to suggest a rapid 10 ascent, the speed (S2) of the decline appears to be small (< 1200 µm 3 /min) for all the thrombi formed at 11 three different shear rates, which is likely to be related to platelet contraction [39, 40] under flow. The 12 quantitative observation of the events is made possible because of the robustness of holographic QPM 13 sensitivity. 14  Characteristics of individual thrombus 15 After the 10 min formation process, we changed the flowing PRP or whole blood sample to the buffer 16 (physiological saline; 0.9% NaCl) at the same shear rate previously used to remove excess PRP or whole 17 blood and then translated the imaging field of view throughout the whole channel to capture images of 18 individual thrombi. Using holographic QPM, we retrieved thrombus volume, surface area and maximum 19 height after numerical reconstruction (see Experimental section) as shown in Figure 3 . (1800 s -1 , 3600 s -1 , 7200 s -1 ). Differences were observed between thrombi generated with heparinized 24 PRP and citrated PRP. The thrombi volumes appeared to be greater for citrated PRP thrombi that could 1 be attributed to the increased in height without a significant increase in area of under which platelet is 2 adhering to. The distribution of the thrombus peak height is presented in the Supplementary material Fig.  3 A1. Within the microfluidic system the thrombus height (heparin PRP and citrated PRP) ranged from 4 1.43 µm to 34.37 µm with median of 8.114 µm ± SD = 4.933. We observed that the volume and area of 5 the individual thrombi from all the donors displayed significant degrees of variation. Hence, it would be 6 of great interest to couple signatures between molecular and morphological information from each 7 thrombus in future studies. However, this would require the combination of fluorescence imaging with 8 holographic QPM [41] to give further information. By using the abundant characteristics information of 9 individual thrombus morphology, it would be very informative to test functionality of platelets by 10 controlled variables such as surface density of platelet receptors which control onset of platelet adhesion 11 and thrombus formation. The phase images retrieved from digital holographic microscopy (DHM) 12 provide the morphological information that is usually examined in platelet study using WFM or CLSM 13 at the same temporal resolution. In addition to that, the morphological information would help developed 14 a better thrombotic numerical model [42] . 15 16  Quantifying embolism 17 The spontaneous embolism of a thrombus especially in acute coronary events may be a natural protective 18 mechanism against infarction in organs [43] . Past studies have focused on individual platelet behaviour 19 and more recently, there has been new interest in investigating factors related to thrombus stability that 20 are able to be correlated with acute coronary events. Here, we investigate overall thrombus stability by 21 perfusing a buffer at a high shear rate over a formed thrombus for a certain period of time and monitored 22 thrombus parameters. The stability test could provide a new perspective to investigate the inner core and 23 the outer shell regions of thrombus [44] . aggregates with equivalent surface areas (1000 -1800 µm 2 ) and similar distance (~ 800 ±200 µm) from 4 the channel inlet. Structural change during the flush could reflect the stability of the thrombus formed. 5 Figure 4 shows the stability test results. show the volume, surface area and height before and after the test. Each dot (circle for a thrombus formed 12 under 1800 s -1 , triangle for 3600 s -1 , square for 7200 s -1 ) in the bar represents the average data (obtained 13 from n>8 data points) from each donor (D2, D3, D4 for citrated PRP, four donors for heparin PRP (d1-14 4) and four donors for heparinized whole blood). The statistical test performed was a paired t-test and 15 significance was observed when p<0.05. There was decreased volume post-perfusion with citrate PRP at 16 3600 s -1 (*p<0.05), due to a reduction in thrombus height (*p<0.05; Figure 4b ) iii and v). Reduction in 17 height was also observed at the same shear rate with heparin PRP, although there was no significant 18 reduction in volume. The rapid decrease in volume with citrated PRP suggests an unstable outer 19 thrombus layer that breaks apart with a residual core thrombus remaining in the same site. This leaves a 20 thrombus of smaller volume and height. However, the surface area of the thrombus is maintained 21 relatively, except for thrombi formed by heparin PRP at 3600 s -1 . In addition, the thrombus formed at 22 lower shear rates (1800 s -1 and 3600 s -1 ) retains a volume, area and height that are smaller than the 23 thrombus formed at 7200 s -1 . We showed that holographic QPM can rapidly track, capture and quantify 1 the rich dynamics of a developing thrombus. 2
Discussion
3
We have shown that the application of holographic QPM provides multi-parameter classification of 4 morphological information in real time. Since depth of focus of the imaging system of QPM is not 5 restricted, QPM retrieves the entire morphological information set of a developing thrombus without any 6 form of labelling. Without QPM, it would require considerable sample preparation and imaging time to 7 retrieve the morphological information. Furthermore, whole blood presents a challenge in optical 8 imaging as red blood cells (RBC) scatter light in a highly directional and ballistic manner, Mie scattering 9 [45] . By combining advanced digital signal processing techniques with digital optical holography this 10 enables the removal of optical scattering and increase imaging resolution. With deterministic 11 microfluidic parameters, the ballistic scattering property of RBC could be removed. We have previously 12
shown that incremental thresholding allows one to retrieve images of an object embedded in a scattering 13 medium [36] . Further, Ferraro and colleagues have demonstrated the use of multi-frame holographic 14 imaging to retrieve images of objects from flowing blood that are "hidden" [46, 47] . However, imaging 15 through turbid or scattered medium remains a major imaging challenge, with holographic microscopy 16 being a key technique [48, 49] . Many more recent techniques in optical holography [47] [48] [49] [50] can be applied to 17 the analysis of thrombus formation in whole blood. However, one main limitation in the application of 18 QPM is the non-specificity of the imaging technique that does not offer additional molecular information 19 i.e. surface receptor levels. To achieve both morphological and molecular imaging, there is a need to 20 combine QPM and high speed fluorescence imaging techniques such as lightsheet microscopy [1] . This 21 provides a greater insight into the dynamic interaction of different receptors and adhesion molecules to 22 thrombus formation. While high speed fluorescence microscopy requires specialized imaging sensors, 23 holographic QPM can operate with more general imaging sensors [51] . Hence, it is plausible to incorporate 24 13 holographic QPM and microfluidic systems into a single portable unit. By reducing the footprint of 1 holographic QPM and using unlabeled samples, it would be possible to use such a compact optofluidic 2 system [52] to directly quantify dynamic thrombus morphology in a clinical setting. Here, we have used 3 a limited number of healthy donors, which would need to be increased to permit comparative studies of 4 thrombus growth rate with a wider distribution of shear rates. This will more accurately portray trends in 5 volumetric growth and reduction over a wider distribution of shear rates. After which, from the clinical 6 perspective, such a system may be effective in testing anticoagulation therapy, identifying platelet 7 dysfunction and monitoring pro-thrombotic stages. 8 9
Experimental Section
10
Blood collection 11
Venous whole blood was collected from consenting, healthy drug-free volunteers into syringes 12 
Microfluidic channel preparation 20
The microfluidic channel (400 µm wide, 100 µm height and 1.2 cm long) was made of transparent 21 polydimethylsiloxane (PDMS) by soft lithography method [52] . Before the experiment, the entire 22 microfluidic channel was coated with collagen Reagent HORM 100 µg/mL (Takeda, Austria: a 23 suspension of native equine tendon collagen type I) and incubated overnight at 4°C. The collagen was 24 added through the outlet to ensure that platelets initially contacted collagen from the entry of the channel 1 beyond the inlet. Before the start of the experiment, the channel was washed using a wash buffer (25 mM 2 TRIS HCl, 150 mM NaCl, pH 7.4) perfused at 300 µL/min for 2 min in the opposite direction of 3 experimental flow. 4
Image and data processing 5
The phase images were reconstructed from holograms recorded by CCD camera, using automatic 6 numerical methods [53] . The volumetric images were calculated from the phase images according to 7 equations below using Matlab (MATLAB R2017a). The standardization of the phase measurement were 8 performed with the 3 µm and 50 µm polystyrene microspheres ( Polybead® Microspheres, polysciences, 9
Inc.). The detail of the standardization can be found in Supplementary materials. In the equations, x and 10 y are the coordinate of the image, representing each pixel. The Phase(x, y) is the phase image and the 11 height (x,y) is the volumetric image. The  is the wavelength of the laser, which is 632.8 nm in our 12 system. The n pt = 1.399 and n pa = 1.332 are the refractive indexes of platelet and the buffer 13 respectively [37] . 14 Individual thrombus image (where x, y ∈ T) is selected from full field image by Otsu's threshold method 15 [32, 54, 55] . The thrombus characteristics evaluated were thrombus peak height, surface area and volume. 16
The thrombus peak height H is the highest point across an individual thrombus image. The thrombus 17 surface area S thrombus is calculated from the summation of pixels covering the thrombus. The is used to calculate the experiment flow rates Q. In the equation, T is the shear 4 stress, b and h are the width and height of the channel, µ is the viscosity of the liquid sample. In our 5 system, channel width is 400 µm, channel height is 100 µm and the viscosity of PRP sample is based 6 on cell culture suspension which is 0.01 dyne/cm 2 * s. The viscosity of whole blood sample is 7 0.045 dyne/cm 2 * s. 8 9
Statistics 10
The volume growth data for thrombus formation is first smoothed by a moving average filter (span=50 11 sampling points, data contains more than 1800 sampling points in total). Then a fitting (polynomial fit 12 with degree of 5 and R-square above 0.98) was applied to each smoothed volume growth line. Two linear 13 fittings (R-square above 0.9) were applied to front and end zone of the polynomial fit, indicated by black 14 lines and the gradient value of the lines are S1 and S2 in the unit of cubic micrometre per minute. The height map images below the line plots are the corresponding thrombus at different time points. 7
The scale bar is 30 µm and colour bar is in micron. 
